| Dr Jeffrey Earl Levea, MD | |
|
5323 Harry Hines Blvd, Dallas, TX 75390-7208 | |
| (214) 633-5555 | |
| Not Available |
| Full Name | Dr Jeffrey Earl Levea |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 15 Years |
| Location | 5323 Harry Hines Blvd, Dallas, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669615936 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | Q5470 (Texas) | Primary |
| 207R00000X | Internal Medicine | Q5470 (Texas) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ut Southwestern Home Health Care | Dallas, TX | Home health agency |
| Ut Southwestern University Hospital - William P. Clements Jr. | Dallas, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
WhiteGlove House Call Health, Inc., an innovative healthcare company that helps consumers lower their healthcare costs while giving them a healthcare experience they love, 365 days a year, at home or work, announced today that Generation America (www.generationamerica.org) has made discounted WhiteGlove memberships available to its members in Texas.
ZIOPHARM Oncology, Inc. announced today that Douglas J. Schwartzentruber, MD, FACS, of the Indiana University Health Goshen Center for Cancer Care, presented initial positive clinical results from the first-ever treatment demonstrating control over transgene encoding of a therapeutic anticancer protein in humans using a small molecule activator ligand.
Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.
Just seeing someone who looks sick is enough to make your immune system work harder, according to a new study in which volunteers looked at pictures of sick people. This may help fight off pathogens, says Mark Schaller from the University of British Columbia who conducted the research. "It seems like it's probably good for the immune system to be responding especially aggressively at times when it looks like you are likely to be coming into contact with something that might make you sick."
› Verified 7 days ago
| Entity Name | University Of Texas Southwestern Medical Center At Dallas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
WhiteGlove House Call Health, Inc., an innovative healthcare company that helps consumers lower their healthcare costs while giving them a healthcare experience they love, 365 days a year, at home or work, announced today that Generation America (www.generationamerica.org) has made discounted WhiteGlove memberships available to its members in Texas.
ZIOPHARM Oncology, Inc. announced today that Douglas J. Schwartzentruber, MD, FACS, of the Indiana University Health Goshen Center for Cancer Care, presented initial positive clinical results from the first-ever treatment demonstrating control over transgene encoding of a therapeutic anticancer protein in humans using a small molecule activator ligand.
Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.
Just seeing someone who looks sick is enough to make your immune system work harder, according to a new study in which volunteers looked at pictures of sick people. This may help fight off pathogens, says Mark Schaller from the University of British Columbia who conducted the research. "It seems like it's probably good for the immune system to be responding especially aggressively at times when it looks like you are likely to be coming into contact with something that might make you sick."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Earl Levea, MD Po Box 845347, Dallas, TX 75284-7208 Ph: () - | Dr Jeffrey Earl Levea, MD 5323 Harry Hines Blvd, Dallas, TX 75390-7208 Ph: (214) 633-5555 |
News Archive
arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announces today that it has entered into an alliance with Shire to create novel therapeutic antibody products against multiple targets submitted by Shire.
WhiteGlove House Call Health, Inc., an innovative healthcare company that helps consumers lower their healthcare costs while giving them a healthcare experience they love, 365 days a year, at home or work, announced today that Generation America (www.generationamerica.org) has made discounted WhiteGlove memberships available to its members in Texas.
ZIOPHARM Oncology, Inc. announced today that Douglas J. Schwartzentruber, MD, FACS, of the Indiana University Health Goshen Center for Cancer Care, presented initial positive clinical results from the first-ever treatment demonstrating control over transgene encoding of a therapeutic anticancer protein in humans using a small molecule activator ligand.
Geron Corporation today announced that the company has entered into a collaboration with University Campus Suffolk (UCS) in the U.K. to develop human embryonic stem cell-derived chondrocytes for the treatment of cartilage damage and joint disease.
Just seeing someone who looks sick is enough to make your immune system work harder, according to a new study in which volunteers looked at pictures of sick people. This may help fight off pathogens, says Mark Schaller from the University of British Columbia who conducted the research. "It seems like it's probably good for the immune system to be responding especially aggressively at times when it looks like you are likely to be coming into contact with something that might make you sick."
› Verified 7 days ago
Preetha Nair, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-645-0624 Fax: 214-645-0078 | |
Michael Burton, MD, MSPH Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-3597 | |
Lavanya Ambujaa Dharmarajan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6201 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-633-5555 | |
Roshni Patel, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 8230 Walnut Hill Ln Ste 620, Dallas, TX 75231 Phone: 214-373-3475 | |
Dr. Apurva Yeluru, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3500 Gaston Ave Ste 550, Dallas, TX 75246 Phone: 214-820-0111 | |
Dr. Nicholas Ragovis, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 5200 Harry Hines Blvd, Dallas, TX 75235 Phone: 214-590-8000 Fax: 212-289-6393 | |
Kenneth Carter Raney, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1441 N Beckley Avenue, Dept Of Medical Education, Dallas, TX 75203 Phone: 214-947-2300 |